Literature DB >> 24461540

Polymyalgia rheumatica--diagnosis and classification.

Gideon Nesher1.   

Abstract

Polymyalgia rheumatica is the most common inflammatory rheumatic disease of the elderly, and shares many pathogenetic and epidemiological features with giant cell arteritis. The typical symptoms are bilateral aching of the shoulder girdle, associated with morning stiffness. The neck and hip girdle may also be involved. The diagnosis of polymyalgia rheumatica is made primarily on clinical grounds. There is no single diagnostic test, but sets of diagnostic or classification criteria have been suggested by several groups of investigators, based on the typical clinical presentation and laboratory evidence of acute-phase reaction. Other conditions that may mimic polymyalgia rheumatic, such as elderly-onset rheumatoid arthritis, must be excluded by appropriate testing and close monitoring of the disease course. Glucocorticoids at low doses (15-20 mg prednisone per day initially) are the mainstay of treatment.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Giant cell arteritis; Glucocorticoids; Morning stiffness; Sedimentation rate

Mesh:

Year:  2014        PMID: 24461540     DOI: 10.1016/j.jaut.2014.01.016

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  10 in total

1.  Early onset polymyalgia rheumatica: two rare cases under age of 50.

Authors:  Jinyoung Park; Duk Hyun Sung
Journal:  Skeletal Radiol       Date:  2017-03-21       Impact factor: 2.199

2.  Patient-Reported Outcomes Following Inpatient Multimodal Treatment Approach in Chronic Pain-Related Rheumatic Diseases.

Authors:  Tobias Romeyke; Elisabeth Noehammer; Harald Stummer
Journal:  Glob Adv Health Med       Date:  2020-08-20

Review 3.  Autoimmunity in 2014.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 4.  The Inflammatory Response in Psoriasis: a Comprehensive Review.

Authors:  Yaxiong Deng; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

5.  Gene expression profiling in patients with polymyalgia rheumatica before and after symptom-abolishing glucocorticoid treatment.

Authors:  Frederik Flindt Kreiner; Rehannah Borup; Finn Cilius Nielsen; Peter Schjerling; Henrik Galbo
Journal:  BMC Musculoskelet Disord       Date:  2017-08-07       Impact factor: 2.362

Review 6.  Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient.

Authors:  Marcin Milchert; Marek Brzosko
Journal:  Indian J Med Res       Date:  2017-05       Impact factor: 2.375

7.  Circadian variations in clinical symptoms and concentrations of inflammatory cytokines, melatonin, and cortisol in polymyalgia rheumatica before and during prednisolone treatment: a controlled, observational, clinical experimental study.

Authors:  Henrik Galbo; Lisbeth Kall
Journal:  Arthritis Res Ther       Date:  2016-07-26       Impact factor: 5.156

8.  Characteristics of Korean Patients with Polymyalgia Rheumatica: a Single Locomotive Pain Clinic Cohort Study.

Authors:  Jong Geol Do; Jinyoung Park; Duk Hyun Sung
Journal:  J Korean Med Sci       Date:  2018-08-10       Impact factor: 2.153

9.  Polymyalgia Rheumatica (PMR) with Normal Values of Both Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentration at the Time of Diagnosis in a Centenarian Man: A Case Report.

Authors:  Ciro Manzo
Journal:  Diseases       Date:  2018-09-20

10.  Diagnosis of giant cell arteritis by head-contrast three-dimensional computed tomography angiography: two case reports.

Authors:  Toshio Kawamoto; Michihiro Ogasawara; Souichiro Nakano; Yuko Matsuki Muramoto; Masakazu Matsushita; Kenjiro Yamanaka; Ken Yamaji; Naoto Tamura
Journal:  J Med Case Rep       Date:  2019-09-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.